{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:45:11Z","timestamp":1787748311139,"version":"build-2784847793"},"reference-count":102,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2025,1,30]]},"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:p>The fifth edition of the WHO classification of haematolymphoid tumours (WHO-HEM5) introduces significant advancements in the understanding and diagnosis of myeloid neoplasms, emphasising molecular and genetic insights. This review highlights key updates from the revised fourth edition (WHO-HEM4R), particularly the integration of genetic criteria for disease classification. Many entities are now defined by specific genetic abnormalities, enhancing diagnostic precision and prognostic assessment. Notably, the elimination of the 20% blast threshold for acute myeloid leukaemia (AML) with specific defining genetic alterations reflects a shift towards genomic-driven diagnostics. Additional updates include the refined subclassification of myelodysplastic neoplasms (MDS) and MDS\/myeloproliferative neoplasms, as well as the recognition of novel entities such as clonal haematopoiesis and MDS with biallelic TP53 inactivation, further expanding the spectrum of myeloid neoplasms. WHO-HEM5 illustrates the diagnostic utility of morphology, flow cytometry, immunohistochemistry and next-generation sequencing in resource-rich settings. However, its implementation in low-income and middle-income countries (LMICs) remains challenging due to limited access to advanced diagnostic tools. This review explores strategies to optimise diagnosis in resource-constrained environments, where morphology and immunophenotyping remain fundamental. By integrating molecular diagnostics with traditional methods, WHO-HEM5 aims to refine classification and facilitate risk stratification in the era of personalised medicine, providing haematopathologists and clinicians with an essential framework to navigate the complexities of myeloid neoplasms. The emphasis on advancing haematopathology practices worldwide, including in LMICs, demonstrates the ongoing commitment to improving global outcomes in haematological malignancies.<\/jats:p>","DOI":"10.1136\/jcp-2024-210022","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T13:21:00Z","timestamp":1739452860000},"page":"335-345","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Fifth edition WHO classification: myeloid neoplasms"],"prefix":"10.1136","volume":"78","author":[{"given":"Xueyan","family":"Chen","sequence":"first","affiliation":[{"name":"Section of Pathology, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA"},{"name":"Department of Laboratory Medicine & Pathology, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Patkar","sequence":"additional","affiliation":[{"name":"Hematopathology Department, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Tata Memorial Centre, Navi Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Tembhare","sequence":"additional","affiliation":[{"name":"Hematopathology Department, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Tata Memorial Centre, Navi Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramanian","family":"Papagudi","sequence":"additional","affiliation":[{"name":"Hematopathology Department, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Tata Memorial Centre, Navi Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecelia","family":"Yeung","sequence":"additional","affiliation":[{"name":"Section of Pathology, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA"},{"name":"Department of Laboratory Medicine & Pathology, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7829-5249","authenticated-orcid":false,"given":"Rashmi","family":"Kanagal Shamanna","sequence":"additional","affiliation":[{"name":"Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet","family":"Gujral","sequence":"additional","affiliation":[{"name":"Hematopathology Department, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Tata Memorial Centre, Navi Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Wood","sequence":"additional","affiliation":[{"name":"Diagnostic Immunology & Flow Cytometry, Children's Hospital Los Angeles, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3807-3638","authenticated-orcid":false,"given":"Kikkeri N","family":"Naresh","sequence":"additional","affiliation":[{"name":"Section of Pathology, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA"},{"name":"Department of Laboratory Medicine & Pathology, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"2025092504000791000_78.5.335.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2020.01.008"},{"key":"2025092504000791000_78.5.335.2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3733"},{"key":"2025092504000791000_78.5.335.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409405"},{"key":"2025092504000791000_78.5.335.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408617"},{"key":"2025092504000791000_78.5.335.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1"},{"key":"2025092504000791000_78.5.335.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2022.106787"},{"key":"2025092504000791000_78.5.335.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716863"},{"key":"2025092504000791000_78.5.335.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01131-6"},{"key":"2025092504000791000_78.5.335.9","doi-asserted-by":"crossref","unstructured":"Weeks LD , Niroula A , Neuberg D , et al . Prediction of risk for myeloid malignancy in clonal hematopoiesis. NEJM Evid 2023;2. doi:10.1056\/evidoa2200310","DOI":"10.1056\/EVIDoa2200310"},{"key":"2025092504000791000_78.5.335.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-020-00710-0"},{"key":"2025092504000791000_78.5.335.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2009.04.002"},{"key":"2025092504000791000_78.5.335.12","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.92"},{"key":"2025092504000791000_78.5.335.13","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25628"},{"key":"2025092504000791000_78.5.335.14","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21958"},{"key":"2025092504000791000_78.5.335.15","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29142"},{"key":"2025092504000791000_78.5.335.16","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.165340"},{"key":"2025092504000791000_78.5.335.17","doi-asserted-by":"crossref","first-page":"E172","DOI":"10.1002\/ajh.25811","article-title":"WHO defined chronic eosinophilic leukemia, not otherwise specified (CEL, NOS): A contemporary series from the Mayo Clinic","volume":"95","author":"Morsia","year":"2020","journal-title":"Am J Hematol"},{"key":"2025092504000791000_78.5.335.18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.7198"},{"key":"2025092504000791000_78.5.335.19","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2005.05.020"},{"key":"2025092504000791000_78.5.335.20","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880269"},{"key":"2025092504000791000_78.5.335.21","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.1.267.413a31_267_272"},{"key":"2025092504000791000_78.5.335.22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0531"},{"key":"2025092504000791000_78.5.335.23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3324\/haematol.2020.270595","article-title":"Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia","volume":"107","author":"Hecht","year":"2022","journal-title":"Haematologica"},{"key":"2025092504000791000_78.5.335.24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-07-728766"},{"key":"2025092504000791000_78.5.335.25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-633537"},{"key":"2025092504000791000_78.5.335.26","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020004850"},{"key":"2025092504000791000_78.5.335.27","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17414"},{"key":"2025092504000791000_78.5.335.28","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013983"},{"key":"2025092504000791000_78.5.335.29","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13529"},{"key":"2025092504000791000_78.5.335.30","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1008-z"},{"key":"2025092504000791000_78.5.335.31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1508054"},{"key":"2025092504000791000_78.5.335.32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-12-754796"},{"key":"2025092504000791000_78.5.335.33","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-022-01273-w"},{"key":"2025092504000791000_78.5.335.34","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0457-1"},{"key":"2025092504000791000_78.5.335.35","doi-asserted-by":"publisher","DOI":"10.1385\/MO:22:2:169"},{"key":"2025092504000791000_78.5.335.36","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.2246"},{"key":"2025092504000791000_78.5.335.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2023.06.006"},{"key":"2025092504000791000_78.5.335.38","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.191"},{"key":"2025092504000791000_78.5.335.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.12.020"},{"key":"2025092504000791000_78.5.335.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2011.01.009"},{"key":"2025092504000791000_78.5.335.41","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.44.4.300"},{"key":"2025092504000791000_78.5.335.42","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004229"},{"key":"2025092504000791000_78.5.335.43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/cancers15123175","article-title":"Myelodysplastic Syndromes\/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review","volume":"15","author":"Fontana","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2025092504000791000_78.5.335.44","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-620781"},{"key":"2025092504000791000_78.5.335.45","first-page":"827","article-title":"Real world implementation of flow cytometric monocyte subset partitioning for distinguishing chronic myelomonocytic leukaemia from other causes of monocytosis","volume":"55","author":"Barge","year":"2023","journal-title":"Pathology (Phila)"},{"key":"2025092504000791000_78.5.335.46","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.11.2915"},{"key":"2025092504000791000_78.5.335.47","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-553800"},{"key":"2025092504000791000_78.5.335.48","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26828"},{"key":"2025092504000791000_78.5.335.49","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD.2022015850"},{"key":"2025092504000791000_78.5.335.50","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008393002748"},{"key":"2025092504000791000_78.5.335.51","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.113159"},{"key":"2025092504000791000_78.5.335.52","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000497","article-title":"Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia","volume":"4","author":"Fontana","year":"2020","journal-title":"Hemasphere"},{"key":"2025092504000791000_78.5.335.53","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000611"},{"key":"2025092504000791000_78.5.335.54","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2495"},{"key":"2025092504000791000_78.5.335.55","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33622"},{"key":"2025092504000791000_78.5.335.56","first-page":"1566","article-title":"Identification of risk factors in atypical chronic myeloid leukemia","volume":"91","author":"Breccia","year":"2006","journal-title":"Haematologica"},{"key":"2025092504000791000_78.5.335.57","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704686"},{"key":"2025092504000791000_78.5.335.58","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.053918"},{"key":"2025092504000791000_78.5.335.59","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2015.1.19"},{"key":"2025092504000791000_78.5.335.60","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.119032"},{"key":"2025092504000791000_78.5.335.61","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24038"},{"key":"2025092504000791000_78.5.335.62","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-008227"},{"key":"2025092504000791000_78.5.335.63","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404373"},{"key":"2025092504000791000_78.5.335.64","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-222331"},{"key":"2025092504000791000_78.5.335.65","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1002\/ajh.26182","article-title":"Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome\/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS\/MPN-RS-T) and myelodysplastic syndrome with ring sideroblasts (MDS-RS)","volume":"96","author":"Montalban-Bravo","year":"2021","journal-title":"Am J Hematol"},{"key":"2025092504000791000_78.5.335.66","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-610543"},{"key":"2025092504000791000_78.5.335.67","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.280487"},{"key":"2025092504000791000_78.5.335.68","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-749903"},{"key":"2025092504000791000_78.5.335.69","doi-asserted-by":"crossref","DOI":"10.1007\/s11912-020-00987-8","article-title":"Access to Therapy for Acute Myeloid Leukemia in the Developing World: Barriers and Solutions","volume":"22","author":"Meillon-Garcia","year":"2020","journal-title":"Curr Oncol Rep"},{"key":"2025092504000791000_78.5.335.70","doi-asserted-by":"publisher","DOI":"10.1186\/gm324"},{"key":"2025092504000791000_78.5.335.71","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1060179","article-title":"Addressing quality and safety in anatomic pathology in low- and middle-income countries","volume":"9","author":"Smith","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2025092504000791000_78.5.335.72","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2"},{"key":"2025092504000791000_78.5.335.73","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20739"},{"key":"2025092504000791000_78.5.335.74","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12916"},{"key":"2025092504000791000_78.5.335.75","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-007013"},{"key":"2025092504000791000_78.5.335.76","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-266908"},{"key":"2025092504000791000_78.5.335.77","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403458"},{"key":"2025092504000791000_78.5.335.78","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2022.106995"},{"key":"2025092504000791000_78.5.335.79","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15725"},{"key":"2025092504000791000_78.5.335.80","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3772"},{"key":"2025092504000791000_78.5.335.81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.06.007"},{"key":"2025092504000791000_78.5.335.82","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15390"},{"key":"2025092504000791000_78.5.335.83","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/ijms20122976","article-title":"Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches","volume":"20","author":"Valent","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2025092504000791000_78.5.335.84","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00038-8"},{"key":"2025092504000791000_78.5.335.85","doi-asserted-by":"publisher","DOI":"10.1111\/his.12221"},{"key":"2025092504000791000_78.5.335.86","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-637728"},{"key":"2025092504000791000_78.5.335.87","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.224"},{"key":"2025092504000791000_78.5.335.88","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2010.550072"},{"key":"2025092504000791000_78.5.335.89","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal","volume":"5","author":"Valent","year":"2021","journal-title":"Hemasphere"},{"key":"2025092504000791000_78.5.335.90","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-3816"},{"key":"2025092504000791000_78.5.335.91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.05.008"},{"key":"2025092504000791000_78.5.335.92","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10711"},{"key":"2025092504000791000_78.5.335.93","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05195-5"},{"key":"2025092504000791000_78.5.335.94","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015545"},{"key":"2025092504000791000_78.5.335.95","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000932"},{"key":"2025092504000791000_78.5.335.96","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.24"},{"key":"2025092504000791000_78.5.335.97","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23672"},{"key":"2025092504000791000_78.5.335.98","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2017.277897"},{"key":"2025092504000791000_78.5.335.99","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(18)30458-6","article-title":"Access to pathology and laboratory medicine services: a crucial gap","volume":"391","author":"Wilson","year":"2018","journal-title":"The Lancet"},{"key":"2025092504000791000_78.5.335.100","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2021-0473-RA"},{"key":"2025092504000791000_78.5.335.101","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqab131"},{"key":"2025092504000791000_78.5.335.102","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01511-6"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp-2024-210022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T11:00:14Z","timestamp":1758798014000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp-2024-210022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":102,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,4,17]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/jcp-2024-210022"],"URL":"https:\/\/doi.org\/10.1136\/jcp-2024-210022","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]}}}